Authors
Loading...
This Note advocates for an expanded Caremark framework for corporate political risk, suggesting it may better protect shareholders and limit corporate influence.
Alexandra Mothner (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: